Clinical Trial

Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy

Name: Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy — clinical trial record (NCT07555301)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SWIAN

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

An observational study tracking the clinical course of patients with IgA nephropathy.

Trial Details

NCT Number	NCT07555301
Lead Sponsor	Waid City Hospital, Zurich
Conditions	IgA Nephropathy (IgAN)
Enrollment	50 participants
Start Date	2026-06-01
Primary Completion	2028-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-29